TRANSLATIONAL MEDICINE: BENCH TO BEDSIDE IN THE CARDIOVASCULAR SCIENCES / MÉDECINE TRANSLATIONNELLE : DU LABORATOIRE AU CHEVET DU PATIENT DANS LE DOMAINE DES SCIENCES CARDIOVASCULAIRES (CCC-181)

Saturday, October 28, 2023

11:00 – 12:00 EST

Location: Palais, 522ABC

Co-Chair(s)

Vibhuti Arya, BSc (she/her/hers)

MSc. Research Coordinator
University of Manitoba
Max Rady College of Medicine
Saif Dababneh, B.Sc

MD/PhD Student
University of British Columbia
University of British Columbia
Braeden Hill

BHSc. Research Assistant
Queen's University
Queen's University

Presenter(s)

Liam R. Brunham, MD PhD FRCPC

Associate Professor
CCS
University of British Columbia
Kim A. Connelly, MBBS, PhD (he/him/his)

Executive Director, Keenan Research Center & Division Head, Cardiology
St.Michael's Hospital, Unity Health Toronto
University of Toronto
Erin E. Mulvihill, PhD

Associate Professor/Scientist
University of Ottawa Heart Institute
University of Ottawa Heart Institute

Disclosure(s):

Vibhuti Arya, BSc: No financial relationships to disclose

Saif Dababneh, B.Sc: No financial relationships to disclose

Braeden Hill: No financial relationships to disclose

Liam R. Brunham, MD PhD FRCPC: Amgen: Consultant/Advisory Board (Ongoing); HLS: Speaker/Honoraria (Ongoing); Novartis: Consultant/Advisory Board (Ongoing); Ultragenyx: Consultant/Advisory Board (Ongoing)

Kim A. Connelly, MBBS, PhD: Abbott: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); AstraZeneca: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Consultant/Advisory Board (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Janssen: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Merck: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Novartis: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); NovoNordisk: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Sanofi: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Servier: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing)

Erin E. Mulvihill, PhD: No financial relationships to disclose

Learning Objectives / Objectifs d'apprentissage:

At the end of this session participants will be able to / Au terme de cette conférence, vous serez:

understand the importance of adopting an interdisciplinary approach blending basic and clinical research in the context of cardiovascular disease;
learn strategies used to translate basic science findings into clinical applications;
identify barriers and facilitators to translating basic science findings into clinical applications;
analyze the clinical applications of translational medicine in cardiovascular sciences and their contribution to patient outcomes; and
discuss the latest advances in translational medicine in the cardiovascular sciences and their potential implications for clinical practice and future research.

Session Description: Basic and translational research lay the foundation for the future of medicine. Recent foundational discoveries have enabled the possibility of gene therapy, stem cell translaplantation, and pharmacogenomics-based personalized medicine. This session will provide insight into how to leverage basic and translational science to improve patient care. The speakers will discuss the highly interdisciplinary approach between basic and clinical science for disease treatment, diagnosis and prevention in various cardiovascular diseases.